A Tribute to Dr. Paul A. J. Janssen: Entrepreneur Extraordinaire, Innovative Scientist, and Significant Contributor to Anesthesiology

  title={A Tribute to Dr. Paul A. J. Janssen: Entrepreneur Extraordinaire, Innovative Scientist, and Significant Contributor to Anesthesiology},
  author={Theodore H. Stanley and Talmage D. Egan and Hugo Van Aken},
  journal={Anesthesia \& Analgesia},
Dr. Paul Janssen was the founder of Janssen Pharmaceutica and the developer of over 80 pharmaceutical compounds that proved useful in human, botanical, and veterinary medicine. He and his coworkers synthesized the fentanyl family of drugs, many other potent analgesics, droperidol, etomidate, and numerous other important medicines that were extremely useful in psychiatry, parasitology, gastroenterology, cardiology, virology, and immunology. Anesthesiology and medicine as a whole have benefited a… 

Figures and Tables from this paper

DARK Classics in Chemical Neuroscience: Carfentanil.

The background, synthesis, manufacture, metabolism, pharmacology, approved indications, dosage, and adverse effects of carfentanil will be discussed along with its emergence as a key player in the ongoing opioid crisis.

Fentanyl and its derivatives as a group of new psychoactive substances (designer drugs)

The purpose of this paper is to present various formulations ofentanyl and to discuss the properties of fentanyl and its derivatives, with particular emphasis on the toxicity of this group of compounds.

The fentanyl story.

  • T. Stanley
  • Medicine
    The journal of pain : official journal of the American Pain Society
  • 2014

DARK Classics in Chemical Neuroscience: Fentanyl.

The impact of fentanyl on chemical neuroscience is shown through its synthesis and properties, manufacturing, metabolism, pharmacology, approved and off-label indications, adverse effects, and the responsibility it has in the opioid epidemic.

The fall and rise of pharmacology--(re-)defining the discipline?

The Pharmacology of Spinal Opioids and Ziconotide for the Treatment of Non-Cancer Pain

Intrathecal therapy has level-one evidence for use for malignant pain and nonmalignant pain, with continued cost savings and improved safety, and a clear appreciation for the pharmacology of commonly employed intrathecal agents is paramount.

Fentanyls continue to replace heroin in the drug arena: the cases of ocfentanil and carfentanil

This review provides information concerning chemistry, synthesis, prevalence, pharmacology, and toxicology, as well as the current legal status of these two fentanyl analogues, which are undeniably very dangerous opioid drugs.

A review of synthetic fentanyl metabolism and the metabolism of select synthetic fentanyl analogues

This review compiles knowledge on in vivo and in vitro metabolism of specific fentanyl analogues to identify common metabolic pathways and fragmentation patterns of key metabolites to assist in the identification of novelentanyl analogues.

Fentanyl: Receptor pharmacology, abuse potential, and implications for treatment




A personal perspective on Dr. Paul Janssen.

  • J. Black
  • Medicine
    Journal of medicinal chemistry
  • 2005
The psychology of his inventiveness was the basis of his unique fecundity and Paul’s intense concentration and passionate commitment were unique in the industry.

Sufentanil, a very potent and extremely safe intravenous morphine-like compound in mice, rats and dogs.

Sufentanil (R 30 730), N-[4-methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenylpropanamide, is a chemically novel, highly potent and extremely safe intravenous morphine-like agent in

Compounds related to pethidine-IV. New general chemical methods of increasing the analgesic activity of pethidine.

New experimental evidence is presented to present new experimental evidence in this field and certain tentative generalizations concerning the structure-activity problem of compounds related to pethidine are arrived at.

Alfentanil (R 39 209) — a particularly short‐acting intravenous narcotic analgesic in rats

Alfentanil reaches its peak effect within 2 min after injection, and its duration of action is very short: at two times its lowest ED50 the drug has aduration of action of 10 min.

Cardiovascular response to large doses of intravenous morphine in man.

In the cardiac but not in the normal subjects, significant increases in cardiac index, stroke index, central venous pressure, and pulmonary-artery pressure were observed after morphine was administered, suggesting that large doses of morphine may be used with safety in patients with minimal circulatory reserve.


An account is given of the pharmacological characteristics of haloperidol and phenoperidine, as manifested in experimental animals.

N-4-Substituted 1-(2-arylethyl)-4-piperidinyl-N-phenylpropanamides, a novel series of extremely potent analgesics with unusually high safety margin.

R 30 730 has a rapid onset of action and is 4521 times more potent than morphine at the time of peak effect; it has a relatively short duration of action comparable to that of fentanyl and its safety margin is unusually high.

Breakthrough: the discovery of modern medicine at Janssen. Morris Plains: Skyline Publishing

  • 1990